AG-86893
Pterygium, Dry Eye
Phase 2/3Completed (pterygium) / Ongoing (dry eye)
Key Facts
Indication
Pterygium, Dry Eye
Phase
Phase 2/3
Status
Completed (pterygium) / Ongoing (dry eye)
Company
About Allgenesis Biotherapeutics
Taiwan biotech developing bispecific ocular biologics for DME, dry eye and AMD.
View full company profile